Clark Nardinelli

U.S. Department of Health & Human Services

Washington, DC 20201

United States

SCHOLARLY PAPERS

2

DOWNLOADS

261

SSRN CITATIONS

2

CROSSREF CITATIONS

2

Scholarly Papers (2)

1.

Fda New Drug Approval Times, Prescription Drug User Fees, and R&D Spending

AEI-Brookings Joint Center Working Paper No. 06-21
Number of pages: 22 Posted: 20 Sep 2006
University of Connecticut - Department of Finance, University of North Carolina (UNC) at Chapel Hill, American Enterprise Institute (AEI) and U.S. Department of Health & Human Services
Downloads 212 (154,175)
Citation 3

Abstract:

Loading...

FDA, R&D, pharmaceutical

2.

Black Box Warnings and Drug Safety: Examining the Determinants and Timing of Fda Warning Labels

NBER Working Paper No. w12803
Number of pages: 23 Posted: 05 Jan 2007 Last Revised: 02 Jun 2013
U.S. Food and Drug Administration (FDA), U.S. Department of Health and Human Services - Food and Drug Administration (FDA), U.S. Department of Health and Human Services - Food and Drug Administration (FDA), American Enterprise Institute (AEI), U.S. Department of Health & Human Services and University of North Carolina (UNC) at Chapel Hill
Downloads 49 (417,823)

Abstract:

Loading...